3results about How to "Increase muscle mass" patented technology

The invention discloses a crystal form A of acetyl L-carnitine hydrochloride, a preparation method of the crystal form A, and a bulk drug, a food additive, a feed additive and a composition containing the crystal form A. The crystal form A of the acetyl L-carnitine hydrochloride is good in solubility, high in stability, high in purity, regular in shape and suitable for being applied to bulk drugs, food additives and feed additives. The preparation method is simple in process, the crystal form A can be obtained at high yield through in-situ crystallization of a reaction solution and dispersion of ethanol, and the preparation method is suitable for large-scale industrial production.

The invention discloses a horse-derived anaerobic strain for improving athletic ability as well as a screening method and application thereof, and relates to the field of microorganisms. The invention discloses a horse-derived anaerobic strain capable of improving athletic ability, which is preserved in China General Microbiological Culture Collection Center, the preservation address is No.3, No.1 yard, Beichen West Road, Chaoyang District, Beijing, the preservation date is September 19, 2023, and the preservation number is CGMCC No.28469. The horse-derived anaerobic strain is classified and named as Enterococcus faecalis. The invention also discloses a screening method and application of the horse-derived anaerobic strain. The horse-derived anaerobic strain for improving the athletic ability, the screening method and the application have important guiding significance on development of probiotics of racing horses and additives of microbial feeds.

This invention discloses a strain of *Lactobacillus delbrueckii* with muscle-protecting function during fat loss, its products, and applications, belonging to the field of microbial technology. The invention discloses *Lactobacillus delbrueckii* subspecies Turb8, with accession number CGMCC No. 35627. This strain or its preparations can effectively prevent or improve muscle loss and functional decline during the use of fat-loss drugs such as GLP-1 receptor agonists (e.g., liraglutide, smegglutide), achieving the effect of "fat loss without muscle loss." While maintaining the original weight-loss effect of fat-loss drugs, the strain of this invention can significantly increase the user's lean body mass percentage, increase lower limb muscle mass, increase muscle fiber cross-sectional area, and improve muscle function indicators such as limb strength and suspension endurance. This invention also relates to bacterial agents containing this strain, various preparations, and their application in the preparation of products for improving (especially drug-induced) muscle loss.